Blog

Home / BRIEF-Bioline says filed regulatory submissions to start Phase 2A trial for BL-8040

BRIEF-Bioline says filed regulatory submissions to start Phase 2A trial for BL-8040

  • 34
  • Jun 28, 2016
June 28 Bioline RX Ltd* Filed regulatory submissions required to commence phase 2a trial for bl-8040 in combination with keytruda in patients with pancreatic cancer * Says study anticipated in q3 of 2016 after receipt of regulatory approval Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
Leave a comment